Entrada Therapeutics · 1 day ago
Principal Scientist, DMPK
Maximize your interview chances
BiotechnologyEmergency Medicine
H1B Sponsor Likely
Insider Connection @Entrada Therapeutics
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Lead all PK- and ADME-related efforts for designated program(s).
Communicate and present relevant information across all areas of the organization, regardless of level.
Select and manage PK/TK, PK/PD, and ADME CROs.
Author and review PK/TK, PK/PD, and ADME reports.
Author and review relevant PK/TK, PK/PD, and ADME sections of regulatory submission documents (e.g. investigational new drug (IND), investigator brochure (IB), clinical trial application (CTA), etc)
Review associated reports, including clinical, toxicology, pharmacology, and bioanalysis.
Collaborate with clinical teams, including pharmacology, biomarkers, development, and operations.
Collaborate with non-clinical development teams, including toxicology and bioanalysis.
Collaborate with discovery teams to guide future programs and better understand mechanisms of action.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
PhD in pharmacology or similar field with 8+ years of DMPK experience in an industry setting or a MS with 12+ years of relevant experience.
Expertise with ADME studies and assays, with a proven track record of strategizing and troubleshooting based upon raw data.
Vendor Management experience, specifically managing CROs.
Experience authoring and reviewing DMPK-related reports and regulatory documents for health authority submissions.
Ability to multi-task effectively and work within aggressive timelines.
Preferred
Additional experience with other aspects of ADME, bioanalytical techniques, PK/PD, toxicokinetics, pre-clinical PK/PD modeling, and translational biology.
Experience with oligonucleotide-based modalities.
Benefits
Competitive health, dental, and vision coverage
Life insurance
Short term and long-term disability insurance
Discretionary time off
Paternity leave
Excellent 401(k) package
Generous transportation stipend
Company
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
H1B Sponsorship
Entrada Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (4)
2022 (6)
2021 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$301.6MKey Investors
Wellington Management
2024-06-24Post Ipo Equity· $100M
2022-12-08Post Ipo Equity· $26M
2021-10-29IPO
Leadership Team
Recent News
GlobeNewswire News Room
2024-12-18
StreetInsider.com
2024-12-09
2024-12-06
Company data provided by crunchbase